Enliven Therapeutics, Inc (ELVN) Misses Q1 EPS by 7c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q1 EPS of ($0.57), $0.07 worse than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Snowflake Inc. (SNOW) PT Raised to $450 at Freedom Broker
• Justice Department halts antitrust cooperation with Canada - report